PL1978936T3 - Kompozycje farmaceutyczne zawierające mieszaniny polimerów i trudno rozpuszczalnych w wodzie substancji czynnych - Google Patents
Kompozycje farmaceutyczne zawierające mieszaniny polimerów i trudno rozpuszczalnych w wodzie substancji czynnychInfo
- Publication number
- PL1978936T3 PL1978936T3 PL07703962T PL07703962T PL1978936T3 PL 1978936 T3 PL1978936 T3 PL 1978936T3 PL 07703962 T PL07703962 T PL 07703962T PL 07703962 T PL07703962 T PL 07703962T PL 1978936 T3 PL1978936 T3 PL 1978936T3
- Authority
- PL
- Poland
- Prior art keywords
- polymers
- water
- pharmaceutical compositions
- active agents
- compositions containing
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006005485 | 2006-02-03 | ||
| PCT/EP2007/050465 WO2007090721A1 (de) | 2006-02-03 | 2007-01-17 | Pharmazeutische zusammensetzungen, enthaltend mischungen aus polymeren und in wasser schlecht löslichen wirkstoffen |
| EP07703962.6A EP1978936B1 (de) | 2006-02-03 | 2007-01-17 | Pharmazeutische Zusammensetzungen, enthaltend Mischungen aus Polymeren und in Wasser schlecht löslichen Wirkstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1978936T3 true PL1978936T3 (pl) | 2013-11-29 |
Family
ID=38229086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07703962T PL1978936T3 (pl) | 2006-02-03 | 2007-01-17 | Kompozycje farmaceutyczne zawierające mieszaniny polimerów i trudno rozpuszczalnych w wodzie substancji czynnych |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090011007A1 (pl) |
| EP (1) | EP1978936B1 (pl) |
| JP (1) | JP2009525300A (pl) |
| KR (1) | KR101387249B1 (pl) |
| CN (1) | CN101370480A (pl) |
| BR (1) | BRPI0707465B8 (pl) |
| CA (1) | CA2641351C (pl) |
| ES (1) | ES2427724T3 (pl) |
| IL (1) | IL191604A (pl) |
| PL (1) | PL1978936T3 (pl) |
| SI (1) | SI1978936T1 (pl) |
| TW (1) | TWI394584B (pl) |
| WO (1) | WO2007090721A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100297248A1 (en) * | 2004-09-01 | 2010-11-25 | Board Of Regents, The University Of Texas System | Encapsulated particles for amorphous stability enhancement |
| US20060045822A1 (en) * | 2004-09-01 | 2006-03-02 | Board Of Regents, The University Of Texas System | Plasma polymerization for encapsulating particles |
| US20100297251A1 (en) * | 2004-09-01 | 2010-11-25 | Board Of Regents, The University Of Texas System | Encapsulated particles for enteric release |
| JP5243247B2 (ja) * | 2005-07-28 | 2013-07-24 | アイエスピー インヴェストメンツ インコーポレイテッド | スプレー乾燥された粉体及び粒状化された材料の特性の改良方法、並びにそれによって製造した製品 |
| GB0607105D0 (en) * | 2006-04-10 | 2006-05-17 | Leuven K U Res & Dev | Enhancing solubility and dissolution rate of poorly soluble drugs |
| US20100173921A1 (en) * | 2006-08-10 | 2010-07-08 | Cipla Limited | Antiretroviral Solid Oral Composition |
| PL382311A1 (pl) * | 2007-04-27 | 2008-11-10 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Kompozycja farmaceutyczna o polepszonej stabilności zawierająca inhibitor acetylocholinoesterazy lub farmaceutycznie dopuszczalną jego sól oraz sposób jej wytwarzania |
| US8088451B2 (en) | 2008-03-13 | 2012-01-03 | Board Of Regents, The University Of Texas System | Covalently functionalized particles for synthesis of new composite materials |
| JP5903686B2 (ja) * | 2010-12-23 | 2016-04-13 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | 固体分散物を基にした固体徐放製剤 |
| EP2550863A1 (de) * | 2011-07-27 | 2013-01-30 | Bayer Intellectual Property GmbH | Aktivstoffhaltige Partikel auf Polyacrylat-Basis |
| US20150011525A1 (en) * | 2011-09-13 | 2015-01-08 | Isp Investments Inc. | Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer |
| EP2833880B1 (en) * | 2012-04-02 | 2017-08-23 | Pharma Seeds Create, LLC | Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer |
| KR101659983B1 (ko) * | 2012-12-31 | 2016-09-26 | 주식회사 삼양바이오팜 | 용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 |
| JP6052319B2 (ja) | 2015-03-25 | 2016-12-27 | Ｎｔｔエレクトロニクス株式会社 | 動画像符号化装置 |
| GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
| US10328771B2 (en) | 2016-06-30 | 2019-06-25 | Emerson Climated Technologies, Inc. | System and method of controlling an oil return cycle for a refrigerated container of a vehicle |
| US10414241B2 (en) | 2016-06-30 | 2019-09-17 | Emerson Climate Technologies, Inc. | Systems and methods for capacity modulation through eutectic plates |
| US10315495B2 (en) | 2016-06-30 | 2019-06-11 | Emerson Climate Technologies, Inc. | System and method of controlling compressor, evaporator fan, and condenser fan speeds during a battery mode of a refrigeration system for a container of a vehicle |
| US10828963B2 (en) | 2016-06-30 | 2020-11-10 | Emerson Climate Technologies, Inc. | System and method of mode-based compressor speed control for refrigerated vehicle compartment |
| US10532632B2 (en) | 2016-06-30 | 2020-01-14 | Emerson Climate Technologies, Inc. | Startup control systems and methods for high ambient conditions |
| US10562377B2 (en) | 2016-06-30 | 2020-02-18 | Emerson Climate Technologies, Inc. | Battery life prediction and monitoring |
| US10569620B2 (en) | 2016-06-30 | 2020-02-25 | Emerson Climate Technologies, Inc. | Startup control systems and methods to reduce flooded startup conditions |
| US10300766B2 (en) * | 2016-06-30 | 2019-05-28 | Emerson Climate Technologies, Inc. | System and method of controlling passage of refrigerant through eutectic plates and an evaporator of a refrigeration system for a container of a vehicle |
| MX2020012458A (es) | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
| CN119236191A (zh) | 2018-05-24 | 2025-01-03 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
| US11689849B2 (en) | 2018-05-24 | 2023-06-27 | Nureva, Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| CN110755396B (zh) * | 2019-12-06 | 2022-04-08 | 北京悦康科创医药科技股份有限公司 | 一种布洛芬缓释小丸及其制备方法 |
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| JP2024515220A (ja) | 2021-04-26 | 2024-04-05 | セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー | 高分子薬剤化合物の持続放出用の埋め込み型デバイス |
| JP7817300B2 (ja) * | 2023-02-14 | 2026-02-18 | 沢井製薬株式会社 | コーティング顆粒、コーティング顆粒を含む製剤及びそれらの製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU85058A1 (fr) | 1983-10-24 | 1985-06-19 | Pharlyse | Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation |
| CA2068402C (en) * | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
| AT403988B (de) * | 1994-05-18 | 1998-07-27 | Lannacher Heilmittel | Festes orales retardpräparat |
| US6391338B1 (en) * | 1995-09-07 | 2002-05-21 | Biovail Technologies Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| US20030064108A1 (en) * | 1996-04-23 | 2003-04-03 | Stefan Lukas | Taste masked pharmaceutical compositions |
| CA2347104A1 (en) * | 1998-10-26 | 2000-04-05 | Tanabe Seiyaku Co., Ltd. | Sustained-release particles |
| FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
| US6656492B2 (en) * | 2000-06-30 | 2003-12-02 | Yamanouchi Pharmaceutical Co., Ltd. | Quick disintegrating tablet in buccal cavity and manufacturing method thereof |
| FR2826274B1 (fr) * | 2001-06-21 | 2003-09-26 | Aventis Pharma Sa | Formulation pharmaceutique au gout masque et son procede de preparation |
| WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
| DE10304403A1 (de) * | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
| US20070098778A1 (en) * | 2004-03-02 | 2007-05-03 | Abeille Pharmaceuticals, Inc. | Co-formulations or kits of bioactive agents |
-
2007
- 2007-01-17 EP EP07703962.6A patent/EP1978936B1/de active Active
- 2007-01-17 KR KR1020087019038A patent/KR101387249B1/ko not_active Expired - Fee Related
- 2007-01-17 US US12/159,538 patent/US20090011007A1/en not_active Abandoned
- 2007-01-17 PL PL07703962T patent/PL1978936T3/pl unknown
- 2007-01-17 CN CNA2007800030537A patent/CN101370480A/zh active Pending
- 2007-01-17 ES ES07703962T patent/ES2427724T3/es active Active
- 2007-01-17 WO PCT/EP2007/050465 patent/WO2007090721A1/de not_active Ceased
- 2007-01-17 SI SI200731314T patent/SI1978936T1/sl unknown
- 2007-01-17 BR BRPI0707465A patent/BRPI0707465B8/pt not_active IP Right Cessation
- 2007-01-17 JP JP2008552772A patent/JP2009525300A/ja active Pending
- 2007-01-17 CA CA2641351A patent/CA2641351C/en active Active
- 2007-02-01 TW TW096103744A patent/TWI394584B/zh not_active IP Right Cessation
-
2008
- 2008-05-21 IL IL191604A patent/IL191604A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| SI1978936T1 (sl) | 2013-10-30 |
| TWI394584B (zh) | 2013-05-01 |
| CA2641351A1 (en) | 2007-08-16 |
| KR101387249B1 (ko) | 2014-05-21 |
| KR20080090494A (ko) | 2008-10-08 |
| CN101370480A (zh) | 2009-02-18 |
| IL191604A0 (en) | 2008-12-29 |
| BRPI0707465B8 (pt) | 2022-07-05 |
| BRPI0707465B1 (pt) | 2020-01-14 |
| IL191604A (en) | 2013-05-30 |
| ES2427724T3 (es) | 2013-10-31 |
| EP1978936B1 (de) | 2013-07-10 |
| CA2641351C (en) | 2014-05-06 |
| TW200808357A (en) | 2008-02-16 |
| WO2007090721A1 (de) | 2007-08-16 |
| US20090011007A1 (en) | 2009-01-08 |
| JP2009525300A (ja) | 2009-07-09 |
| BRPI0707465A2 (pt) | 2011-05-03 |
| EP1978936A1 (de) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191604A0 (en) | Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water | |
| IL272235A (en) | Preparations containing pharmaceutical agents that hardly dissolve in water and antimicrobial agents | |
| IL272236A (en) | Preparations and methods for preparing drugs that are hardly soluble in water with increased stability | |
| IL184563A (en) | Pharmaceutical foam formulations and their use | |
| IL192053A (en) | 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation | |
| IL197275A0 (en) | Pharmaceutical compositions of clonazepam and methods of use thereof | |
| IL195161A0 (en) | Pharmaceutical compositions of ropinirole and methods of use thereof | |
| IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
| ZA200807600B (en) | Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue | |
| IL197871A0 (en) | Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers | |
| HU0700828D0 (en) | Transdermal pharmaceutical compositions containing tol perisone alone and in combination | |
| IL193268A0 (en) | Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia | |
| IL185096A0 (en) | Polymer compositions and their use in the production of active or effective ingredient compositions | |
| GB0614365D0 (en) | Pharmaceutical compositions and their use | |
| IL189827A0 (en) | Pharmaceutical dosage forms and compositions comprising lecoztan | |
| PL2258361T3 (pl) | Zastosowanie pochodnej benzofenonu lub jej soli w kombinacji z inhibitorem TNFα i kompozycja farmaceutyczna zawierająca pochodną lub jej sól oraz inhibitor | |
| IL196558A0 (en) | Crystal form of epothilone b and use in pharmaceutical compositions | |
| ZA200802763B (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
| ZA200902498B (en) | Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers | |
| GB0724523D0 (en) | Pharmaceutical compositions comprising clotrimazole or analogs thereof and their use | |
| HU0600046D0 (en) | Pharmaceutical composition and it's use | |
| HU0600381D0 (en) | Pharmaceutical composition and it's use | |
| ZA200806639B (en) | Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the prodection thereof, and use thereof | |
| IL178937A0 (en) | Pharmaceutical and cosmetic compositions | |
| ZA200807876B (en) | Use of TPO peptide compounds and pharmaceutical compositions in the treatment of anemia |